Advertisement

Ads Placeholder
Loading...

Delota Corp.

SYDRFPNK
Healthcare
Medical - Pharmaceuticals
$0.10
$0.00(0.00%)
U.S. Market opens in 49h 11m

Delota Corp. Fundamental Analysis

Delota Corp. (SYDRF) shows moderate financial fundamentals with a PE ratio of -9.43, profit margin of -1.15%, and ROE of -41.90%. The company generates $0.0B in annual revenue with strong year-over-year growth of 31.35%.

Key Strengths

Cash Position49.62%
PEG Ratio0.03

Areas of Concern

ROE-41.90%
Operating Margin-0.95%
Current Ratio0.77
We analyze SYDRF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -18.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-18.8/100

We analyze SYDRF's fundamental strength across five key dimensions:

Efficiency Score

Weak

SYDRF struggles to generate sufficient returns from assets.

ROA > 10%
-3.38%

Valuation Score

Excellent

SYDRF trades at attractive valuation levels.

PE < 25
-9.43
PEG Ratio < 2
0.03

Growth Score

Moderate

SYDRF shows steady but slowing expansion.

Revenue Growth > 5%
31.35%
EPS Growth > 10%
-1.27%

Financial Health Score

Weak

SYDRF carries high financial risk with limited liquidity.

Debt/Equity < 1
7.72
Current Ratio > 1
0.77

Profitability Score

Weak

SYDRF struggles to sustain strong margins.

ROE > 15%
-4190.41%
Net Margin ≥ 15%
-1.15%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is SYDRF Expensive or Cheap?

P/E Ratio

SYDRF trades at -9.43 times earnings. This suggests potential undervaluation.

-9.43

PEG Ratio

When adjusting for growth, SYDRF's PEG of 0.03 indicates potential undervaluation.

0.03

Price to Book

The market values Delota Corp. at 5.85 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.85

EV/EBITDA

Enterprise value stands at 0.07 times EBITDA. This is generally considered low.

0.07

How Well Does SYDRF Make Money?

Net Profit Margin

For every $100 in sales, Delota Corp. keeps $-1.15 as profit after all expenses.

-1.15%

Operating Margin

Core operations generate -0.95 in profit for every $100 in revenue, before interest and taxes.

-0.95%

ROE

Management delivers $-41.90 in profit for every $100 of shareholder equity.

-41.90%

ROA

Delota Corp. generates $-3.38 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.38%

Following the Money - Real Cash Generation

Operating Cash Flow

Delota Corp. generates limited operating cash flow of $1.48M, signaling weaker underlying cash strength.

$1.48M

Free Cash Flow

Delota Corp. produces free cash flow of $1.37M, offering steady but limited capital for shareholder returns and expansion.

$1.37M

FCF Per Share

Each share generates $0.05 in free cash annually.

$0.05

FCF Yield

SYDRF converts 33.84% of its market value into free cash.

33.84%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-9.43

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.85

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

7.72

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.77

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.42

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.07

vs 25 benchmark

How SYDRF Stacks Against Its Sector Peers

MetricSYDRF ValueSector AveragePerformance
P/E Ratio-9.4328.45 Better (Cheaper)
ROE-41.90%763.00% Weak
Net Margin-1.15%-45265.00% (disorted) Weak
Debt/Equity7.720.34 Weak (High Leverage)
Current Ratio0.772795.60 Weak Liquidity
ROA-3.38%-16588.00% (disorted) Weak

SYDRF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Delota Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

162.14%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

75.99%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

123.82%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ